-
CPHI China opens for international partnering after China rises in CPHI Index
Market news
PharmaSources.comJune 08, 2022
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
-
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Market news
PharmaSourcesFebruary 02, 2023
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
-
Coriolis Pharma Strengthens its Presence in North America by Appointing Formulation Expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board
Market news
PharmaSourcesFebruary 01, 2023
Prof. Dr. Reza Nejadnik's research at the University of Iowa, College of Pharmacy, is focused on protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces.
-
Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
Market news
PharmaSourcesJanuary 26, 2023
ProBioGen today announced that a Novartis clinical candidate using its antibody-dependent cellular cytotoxicity (ADCC) technology, GlymaxX, has reached Phase III.
-
First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated
Market news
PharmaSourcesJanuary 23, 2023
OxSonics Therapeutics, announces that first-in-human clinical data demonstrated that SonoTran® is safe and well-tolerated, with consistent Particle activation observed and mapped using OxSonics’ proprietary “see-as-you-treat” technology.
-
SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab
Market news
PharmaSourcesJanuary 19, 2023
SOTIO Biotech announced today that the first patient was dosed in its Phase 2 AURELIO-05 combination trial of nanrilkefusp alfa (previously known as SOT101), an IL-15 superagonist, and cetuximab in patients with colorectal cancer.
-
osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer
Market news
PharmaSourcesJanuary 19, 2023
So far osteolabs has successfully applied its proprietary Calcium Isotope Marker Technology for the early detection and therapy monitoring in the field of osteoporosis.
-
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Market news
PharmaSourcesJanuary 12, 2023
Expands Drug Development and FDA Regulatory Expertise
-
Novotech Acquires European CRO, Strengthens Global Operations
Market news
PharmaSourcesJanuary 12, 2023
The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees.
-
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)
Market news
PharmaSourcesJanuary 12, 2023
HighTide Therapeutics Inc. announced the dosing of the first patient in a Phase 2b clinical study evaluating HTD1801 for the treatment of nonalcoholic steatohepatitis ("NASH").